A recent article on Forbes.com discusses the significance of Aptar Pharma’s expanded relationship with Propeller Health to deliver Connected Medicines across multiple therapeutic areas. Announced May 30, this partnership, which includes a strategic equity investment by Aptar Pharma in Propeller Health, is “a move that signals the pharmaceutical industry’s growing interest in digital therapeutics.”
Read the full article where Forbes covers Aptar Pharma/Propeller Health work on connected medicine.
